Larvol Delta - Preclinical-and-pilot-study-of-type-I-FLT3-tyrosine-kinase-inhibitor-crenolanib-with-sorafenib-in-acute-myeloid-leukemia-and-FLT3internal-tandem-duplication

Nexavar (sorafenib) - Bayer, Amgen

crenolanib besylate (ARO-002) - AROG

http://www.ncbi.nlm.nih.gov/pubmed/35344039

Mar 29, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next